|
Year to Jun 2025
12 months to Jun 30, 2025
|
Year to Jun 2024
12 months to Jun 30, 2024
|
|
|---|---|---|
| Cash Flows From Operating Activities: | ||
| Net (Loss) Income | ||
| Adjustments to reconcile net (loss) income to net cash used in operating activities: | ||
| Depreciation and amortization expenses | ||
| Amortization of operating lease right-of-use assets | ||
| (Gain) loss from early termination of right-of-use assets | ||
| Share-based compensation expenses | ||
| Provision for doubtful receivables | ||
| Gain from extinguishment of liability | ||
| Accretion of interest expenses on convertible notes | ||
| Loss from extinguishment of convertible notes | ||
| Changes in fair value of derivative liabilities | ||
| Changes in fair value of warrant liabilities | ||
| Deferred income tax expenses (benefits) | ||
| Changes in operating assets and liabilities: | ||
| Accounts receivable | ||
| Due from related parties | ||
| Prepaid expenses and other current assets | ||
| Other non-current assets | ||
| Accounts payable | ||
| Insurance premium payable | ||
| Due to related parties | ||
| Income tax payable | ||
| Operating lease liabilities | ||
| Accrued expenses and other liabilities | ||
| Net cash used in operating activities | ||
| Cash Flows From Investing Activities | ||
| Purchase of property and equipment | ||
| Prepayments or purchase for intangible assets | ||
| Prepayment for equity investments | ||
| Investment in an equity investee | ||
| Net cash provided by (used in) investing activities | ||
| Cash Flows From Financing Activities | ||
| Proceeds from IPO | ||
| Proceeds from over-allotment | ||
| Net proceeds from issuance of convertible notes | ||
| Repayment of convertible notes | ||
| Capital contribution from a shareholder | ||
| Proceeds from short-term bank borrowings | ||
| Repayment of short-term bank borrowings | ||
| Repayment of short-term borrowings | ||
| Borrowings from related parties | ||
| Repayment of borrowings to related parties | ||
| Settlement of subscription fees advanced from a investor | ||
| Payment of offering cost | ||
| Net cash (used in) provided by financing activities | ||
| Effect of exchange rate changes on cash and cash equivalents | ||
| Net increase (decrease) in cash, cash equivalents and restricted cash | ||
| Cash, cash equivalents and restricted cash at beginning of the year | ||
| Cash, cash equivalents and restricted cash at end of the year | ||
| Supplemental Cash Flow Information | ||
| Cash paid for interest expense | ||
| Non-cash Investing and Financing activities | ||
| Operating lease right-of-use assets obtained in exchange for operating lease liabilities | ||
| Disposal of operating lease right-of-use assets | ||
| Issuance of warrants to underwriter in connection with IPO and overallotment | ||
| Issuance of shares to settlement convertible notes | ||
| Reconciliation of cash, cash equivalents and restricted cash to the consolidated balance sheets | ||
| Cash and cash equivalents | ||
| Restricted cash | ||
| Restricted cash, noncurrent | ||
| Total cash and cash equivalents and restricted cash |
Loading...